Nuclear CD133 expression predicts poor prognosis for hepatocellular carcinoma.

Yu, Gui-Fang; Lin, Xian; Luo, Rong-Cheng; Fang, Wei-Yi

Yu, Gui-Fang; Lin, Xian; Luo, Rong-Cheng; Fang, Wei-Yi.

Afiliación

Yu GF; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University Guangzhou, Guangdong, People's Republic of China.
Lin X; Cancer Center, Southern Medical University Guangzhou, Guangdong, People's Republic of China.
Luo RC; Department of Oncology, The Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, People's Republic of China.
Fang WY; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University Guangzhou, Guangdong, People's Republic of China.

Int J Clin Exp Pathol ; 11(4): 2092-2099, 2018.

Article en En | MEDLINE | ID: mdl-31938317

Palabras clave

CD133; hepatocellular carcinoma; nuclear expression; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Clin Exp Pathol Asunto de la revista: PATOLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google